We recently reported that a decrease in miR-184 by miR-21 promotes tumor malignancy and poor outcomes in non-small cell lung cancer (NSCLC) via targeting CDC25A and c-Myc [5]. Here, CDC25A is linked to non-small cell lung carcinoma.